Stay updated on LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Sign up to get notified when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.1 to v3.7.2; the study page remains a 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T14:07:01.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-12T14:41:49.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The study record now displays a 403 Forbidden page, blocking access to the study details and related sections.
    Difference
    19%
    Check dated 2026-09-21T20:24:04.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.6.6, replacing Revision: v3.6.5; this indicates a small update to the site framework without changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-31T18:17:39.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    Footer revision updated to v3.6.5, representing a site update/version bump. No changes to the study details, eligibility criteria, or results are introduced.
    Difference
    0.1%
    Check dated 2026-08-10T13:24:04.000Z thumbnail image
  7. Check
    90 days ago
    Change Detected
    Summary
    The page shows a new revision number (v3.6.4) indicating a recent update to the ClinicalTrials.gov record. No study details or terms appear to be changed in the visible context.
    Difference
    0.1%
    Check dated 2026-07-27T05:53:58.000Z thumbnail image

Stay in the know with updates to LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LowDose IL-2 & Pembrolizumab in Melanoma/RCC Clinical Trial page.